Literature DB >> 32971238

Blood M2a monocyte polarization and increased formyl peptide receptor 1 expression are associated with progression from latent tuberculosis infection to active pulmonary tuberculosis disease.

Yung-Che Chen1, Yu-Ping Chang2, Chang-Chun Hsiao3, Chao-Chien Wu4, Yi-Hsi Wang5, Tung-Ying Chao6, Sum-Yee Leung7, Wen-Feng Fang8, Chiu-Ping Lee9, Ting-Ya Wang10, Po-Yuan Hsu11, Meng-Chih Lin12.   

Abstract

OBJECTIVES: This study aims to explore the role of M2a polarization and formyl peptide receptor (FPR) regulation in the reactivation of Mycobacterium tuberculosis (Mtb) infection.
METHODS: M1/M2a monocyte percentage and FPR1/2/3 protein expression of blood immune cells were measured in 38 patients with sputum culture (+) active pulmonary TB disease, 18 subjects with latent TB infection (LTBI), and 28 noninfected healthy subjects (NIHS) using flow cytometry method.
RESULTS: M1 percentage was decreased in active TB versus either NIHS or LTBI group, while M2a percentage and M2a/M1 percentage ratio were increased. FPR1 expression on M1/M2a, FPR2 expression on M1, and FPR3 expression of M1 were all decreased in active TB versus LTBI group, while FPR1 over FPR2 expression ratio on NK T cell was increased in active TB versus either NIHS or LTBI group. In 11 patients with active TB disease, M1 percentage became normal again after anti-TB treatment. In vitro Mtb-specific antigen stimulation of monocytic THP-1 cells resulted in M2a polarization in association with increased FPR2 expression on M2a.
CONCLUSIONS: Increased M2a and decreased M1 phenotypes of blood monocyte may serve as a marker for active TB disease, while decreased FPR1 on blood monocyte may indicate LTBI status.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Active tuberculosis disease; Formyl peptide receptor1/2/3; Latent tuberculosis infection; M1 monocyte; M2a polarization

Mesh:

Substances:

Year:  2020        PMID: 32971238     DOI: 10.1016/j.ijid.2020.09.1056

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  5 in total

1.  Pyridazinones and Structurally Related Derivatives with Anti-Inflammatory Activity.

Authors:  Niccolo Cantini; Igor A Schepetkin; Nadezhda V Danilenko; Andrei I Khlebnikov; Letizia Crocetti; Maria Paola Giovannoni; Liliya N Kirpotina; Mark T Quinn
Journal:  Molecules       Date:  2022-06-10       Impact factor: 4.927

2.  Activation Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection.

Authors:  Ying Luo; Ying Xue; Liyan Mao; Qun Lin; Guoxing Tang; Huijuan Song; Wei Liu; Shutao Tong; Hongyan Hou; Min Huang; Renren Ouyang; Feng Wang; Ziyong Sun
Journal:  Front Immunol       Date:  2021-08-26       Impact factor: 7.561

3.  Suppression of FPR2 expression inhibits inflammation in preeclampsia by improving the biological functions of trophoblast via NF-κB pathway.

Authors:  Shuxian Li; Anna Li; Liping Zhai; Yaqiong Sun; Ling Yu; Zhenya Fang; Lin Zhang; Yanjie Peng; Meihua Zhang; Xietong Wang
Journal:  J Assist Reprod Genet       Date:  2022-01-11       Impact factor: 3.412

Review 4.  Annexin-A1: The culprit or the solution?

Authors:  Lauren Kelly; Sarah McGrath; Lewis Rodgers; Kathryn McCall; Aysin Tulunay Virlan; Fiona Dempsey; Scott Crichton; Carl S Goodyear
Journal:  Immunology       Date:  2022-03-01       Impact factor: 7.215

5.  Up-regulated long noncoding RNA AC007128.1 and its genetic polymorphisms associated with Tuberculosis susceptibility.

Authors:  Hong Yan; Guoye Liu; Yuan Liang; Wei Wu; Rui Xia; Lin Jiao; Han Shen; Zhijun Jia; Qian Wang; Zhiqiang Wang; Yi Kong; Binwu Ying; Hualiang Wang; Chengbin Wang
Journal:  Ann Transl Med       Date:  2021-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.